National Healthcare Corp. (NHC) is a publicly traded Healthcare sector company. As of May 21, 2026, NHC trades at $199.51 with a market cap of $3.07B and a P/E ratio of 24.87. NHC moved +1.28% today. Year to date, NHC is +52.38%; over the trailing twelve months it is +88.84%. Its 52-week range spans $89.14 to $205.06. Rallies surfaces NHC's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
What changed in NHC news today?
National HealthCare Q4 Profit $24.8M, FY Revenue up 16.1%: National HealthCare posted Q4 net income of $24.8M ($1.58 GAAP, $1.83 adjusted) on revenue of $386.5M. For FY2025, the company reported $120M profit ($7.67 per share) on $1.52B revenue, a 16.1% year-over-year revenue increase driven by 8.4% same-facility growth and White Oak acquisition.
Shelly Timothy J. sold 2.45K (~$342.14K) on Dec 17, 2025.
HASSAN EMIL E sold 7.50K (~$1.04M) on Nov 25, 2025.
Flatt Stephen Fowler sold 1.00K (~$130.33K) on Nov 21, 2025.
NHC Analyst Consensus
NHC analyst coverage data. Average price target: $0.00.
Common questions about NHC
What changed in NHC news today?
National HealthCare Q4 Profit $24.8M, FY Revenue up 16.1%: National HealthCare posted Q4 net income of $24.8M ($1.58 GAAP, $1.83 adjusted) on revenue of $386.5M. For FY2025, the company reported $120M profit ($7.67 per share) on $1.52B revenue, a 16.1% year-over-year revenue increase driven by 8.4% same-facility growth and White Oak acquisition.
Does Rallies summarize NHC news?
Yes. Rallies summarizes NHC news with ticker-specific context, catalysts, source links, and AI-generated market summaries when news is available.
Is NHC research on Rallies investment advice?
No. Rallies provides research, data, and educational context for NHC. It does not provide personalized investment advice.
